Recent News

• 08.14.2025 - INVO Fertility Announces Second Quarter 2025 Financial Results
• 07.17.2025 - INVO Fertility Announces a 1:3 Reverse Stock Split Effective Pre-Market Opening on July 21, 2025
• 07.09.2025 - INVO Fertility Enhances INVOcell Technology with Expanded Awareness, Training, and Improved Pricing
• 06.30.2025 - INVO Fertility Adds Platelet-Rich Plasma Therapy Capabilities at Wisconsin Fertility Institute
• 06.25.2025 - INVO Fertility Receives Notice of Allowance for Modified INVOcell Device Patent
• 06.20.2025 - INVO Fertility Reminds Shareholders to Cast Their Vote for Upcoming Annual Meeting of Shareholders to be held on Wednesday, June 25, 2025 at 12:00 p.m. Eastern Time
• 06.18.2025 - INVO Fertility Expands Telehealth Capabilities at Its Wisconsin Fertility Institute
• 06.16.2025 - INVO Fertility’s Wisconsin Clinic Recognized on Newsweek’s List of America’s Best Fertility Clinics for 2025

Recent Filings

• 08.01.2025 - 8-K Current report
• 07.23.2025 - 8-K Current report
• 07.21.2025 - 8-K Current report
• 07.21.2025 - EX-99.1 EX-99.1
• 07.17.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 07.10.2025 - 8-K Current report
• 07.01.2025 - 8-K Current report
• 06.25.2025 - 8-K Current report
• 06.23.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 06.06.2025 - 8-K Current report